During the past decade, The Neurology Foundation, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Neurology Foundation, Inc." #1 sponsor was "Acorda Therapeutics" with 1 trials, followed by "Cognition Pharmaceuticals, LLC" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Genzyme, a Sanofi Company" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Neurology Foundation, Inc." #1 collaborator was "Bayer" with 1 trials as a collaborator and "Immune Tolerance Network (ITN)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Neurology Foundation, Inc." are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Cognition Disorders" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "The Neurology Foundation, Inc." in a lesser frequency.

Most popular intervention types in "The Neurology Foundation, Inc." are "Drug" (5 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ocrelizumab" (2 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials) and "C105" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Neurology Foundation, Inc." are 6 trials for "All" genders.

Currently, there are NaN active trials in "The Neurology Foundation, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Neurology Foundation, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Neurology Foundation, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".